SemiAnalysis: AI Semiconductor Construction Bottleneck May Extend to Key Materials Such as Tungsten
BlockBeats News, June 30th - Semiconductor and AI independent research firm SemiAnalysis published an article stating that one of the most underestimated ways to participate in AI semiconductor development may not be the chip itself, but rather the materials. As the industry accelerates the production of more advanced semiconductors, demand growth is not only seen in GPUs and wafer fab equipment, but also in the key materials that support modern chip manufacturing.
Take tungsten, for example. Tungsten is one of the most critical materials in semiconductor manufacturing, valued for its high-temperature stability and resistance to electrical erosion. Wafer fabs rely on chemical vapor deposition to fill deep high aspect ratio vertical vias that interconnect multiple layers in chip architecture, while using physical vapor deposition to deposit ultra-thin barrier layers around them. As tungsten covers both core deposition steps, it is irreplaceable in advanced chip production.
Tungsten supply seems to be increasingly constrained. High-purity tungsten metal powder is the primary raw material for manufacturing tungsten hexafluoride, a gas used in chemical vapor deposition. Japan is home to key tungsten hexafluoride suppliers like SK Materials and Shin-Etsu Chemical, but is facing significantly higher prices and a sharp decrease in tungsten raw material imports, making it almost impossible to continue producing critical tungsten hexafluoride materials. The price pressure is also evident in the import price of Korean tungsten hexafluoride, which has risen by 151% this year. As semiconductor complexity and AI demand rise, bottlenecks may not only appear in chips or equipment, but also in the crucial materials at the bottom of the supply chain.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
Debt and inflation become the biggest constraints! Deutsche Bank warns: The global market "policy safety net" is failing and future volatility may intensify
Deutsche Bank Research stated in its latest report that the era of large-scale policy interventions used to cushion global economic shocks over the past decades is coming to an end. The continuous rise in sovereign debt, high interest rates, and persistent inflation are all weakening the traditional “safety net” relied upon by governments and central banks.
Bellock executive Lee Young Hoon lifts stake to 0.99% from 0.56%
